Kalogeraki Alexandra, Papadakis Georgios Z, Tamiolakis Dimitrios, Karvela-Kalogeraki Iliana, Karvelas-Kalogerakis Mihailos, Segredakis John, Papadakis Michael, Moustou Eleni, Datseri Galateia, Tzardi Maria
Rom J Intern Med. 2016 Jan-Mar;54(1):24-30. doi: 10.1515/rjim-2016-0002.
Solid masses of the pancreas represent a variety of benign and malignant neoplasms of the exocrine and endocrine tissues of the pancreas. A tissue diagnosis is often required to direct therapy in the face of uncertain diagnosis or if the patient is not a surgical candidate either due to advanced disease or comorbidities. Endoscopic ultrasound (EUS) is a relatively new technology that employs endoscopy and high-frequency ultrasound (US). EUS involves imaging of the pancreatic head and the uncinate from the duodenum and imaging of the body and tail from the stomach. It has been shown to be a highly sensitive method for the detection of pancreatic masses. It is superior to extracorporeal US and computed tomographic (CT) scans, especially when the pancreatic tumor is smaller than 2-3 cm. Although EUS is highly sensitive in detecting pancreatic solid masses, its ability to differentiate between inflammatory masses and malignant disease is limited. Endoscopic retrograde cholangiopancreatography (ERCP) brushing, CT-guided biopsies, and transabdominal ultrasound (US) have been the standard nonsurgical methods for obtaining a tissue diagnosis of pancreatic lesions, but a substantial false-negative rate has been reported. Transabdominal US-guided fine-needle aspiration biopsy (US-FNAB) has been used for tissue diagnosis in patients with suspected pancreatic carcinoma. It has been shown to be highly specific, with no false-positive diagnoses. With the advent of curvilinear echoendoscopes, transgastric and transduodenal EUS-FNAB of the pancreas have become a reality EUS with FNAB has revolutionized the ability to diagnose and stage cancers of the gastrointestinal tract and assess the pancreas. Gastrointestinal cancers can be looked at with EUS and their depth of penetration into the intestinal wall can be determined. Any suspicious appearing lymph nodes can be biopsied using EUS/FNAB. The pancreas is another organ that is well visualized with EUS. Abnormalities such as tumors and cysts of the pancreas can be carefully evaluated using EUS and then biopsied with FNAB. There are many new applications of EUS using FNAB. Researchers are looking to deliver chemotherapeutics into small pancreatic cancers and cysts. Nerve blocks using EUS/FNAB to inject numbing medicines into the celiac ganglia, a major nerve cluster, are now routinely performed in patients with pain due to pancreatic cancer. The aim of this study is to perform a review of the literature regarding the usefulness of EUS/FNAB in the diagnosis of pancreatic adenocarcinoma.
胰腺实性肿块代表胰腺外分泌和内分泌组织的多种良性和恶性肿瘤。面对诊断不明确的情况,或者患者由于疾病进展或合并症而不适合手术时,通常需要进行组织诊断以指导治疗。内镜超声(EUS)是一项相对较新的技术,它结合了内镜检查和高频超声(US)。EUS包括从十二指肠对胰头和钩突进行成像,以及从胃对胰体和胰尾进行成像。它已被证明是检测胰腺肿块的一种高度敏感的方法。它优于体外超声和计算机断层扫描(CT),特别是当胰腺肿瘤小于2 - 3厘米时。尽管EUS在检测胰腺实性肿块方面高度敏感,但其区分炎性肿块和恶性疾病的能力有限。内镜逆行胰胆管造影(ERCP)刷检、CT引导下活检和经腹超声(US)一直是获取胰腺病变组织诊断的标准非手术方法,但据报道存在相当高的假阴性率。经腹超声引导下细针穿刺活检(US - FNAB)已用于疑似胰腺癌患者的组织诊断。它已被证明具有高度特异性,无假阳性诊断。随着曲线形超声内镜的出现,经胃和经十二指肠的胰腺EUS - FNAB已成为现实。EUS结合FNAB彻底改变了胃肠道癌症的诊断和分期能力以及评估胰腺的能力。可以通过EUS观察胃肠道癌症,并确定其浸润肠壁的深度。任何可疑的淋巴结都可以使用EUS/FNAB进行活检。胰腺是另一个通过EUS能很好显示的器官。胰腺的异常情况,如肿瘤和囊肿,可以通过EUS仔细评估,然后用FNAB进行活检。EUS结合FNAB有许多新的应用。研究人员正在寻求将化疗药物注入小胰腺癌和囊肿中。使用EUS/FNAB将麻醉药物注入主要神经丛腹腔神经节的神经阻滞,现在已常规用于因胰腺癌而疼痛的患者。本研究的目的是对关于EUS/FNAB在胰腺腺癌诊断中的有用性的文献进行综述。